| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/08/2000 | WO2000032776A2 Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
| 06/08/2000 | WO2000032754A1 An improved method for the production and purification of adenoviral vectors |
| 06/08/2000 | WO2000032752A1 Psca: prostate stem cell antigen and uses thereof |
| 06/08/2000 | WO2000032751A2 Mammalian non-neuronal cells that are modified to store and release a neurotransmitter |
| 06/08/2000 | WO2000032750A1 Transgenic circulating endothelial cells |
| 06/08/2000 | WO2000032631A2 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof |
| 06/08/2000 | WO2000032520A1 Method for activating water and use of activated water of this type |
| 06/08/2000 | WO2000032253A1 Radiopaque implantable collagenous biomaterial device |
| 06/08/2000 | WO2000032251A1 Porous composite matrix and the production and use thereof |
| 06/08/2000 | WO2000032250A1 A multi-formed collagenous biomaterial medical device |
| 06/08/2000 | WO2000032233A2 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| 06/08/2000 | WO2000032224A2 Calcitonin for the modulation of sperm function |
| 06/08/2000 | WO2000032220A1 Anti-dandruff composition comprising an antifungal polypeptide |
| 06/08/2000 | WO2000032209A2 Submucosa modulation of mammalian immune response |
| 06/08/2000 | WO2000032208A2 Isolated material having an anti-organotrophic effect |
| 06/08/2000 | WO2000032207A1 Spray delivery of cells |
| 06/08/2000 | WO2000032184A1 Skin preparations for external use |
| 06/08/2000 | WO2000032112A1 Embolization device |
| 06/08/2000 | WO2000016786A3 Oxihumic acid and its use in the treatment of various conditions |
| 06/08/2000 | WO2000015820A8 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 06/08/2000 | WO2000015245A3 Stable liquid formulations of botulinum toxin |
| 06/08/2000 | WO2000013693A3 Antipollution plant complex, production process and utilization of said complex in the preparation of pharmaceutical and/or cosmetic compositions |
| 06/08/2000 | WO2000011183A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/08/2000 | WO2000010580A3 Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders |
| 06/08/2000 | WO2000010550A3 Reduction of surfactant inactivation in pulmonary surfactant therapy |
| 06/08/2000 | WO2000008191A3 Herpes virus vectors for dendritic cells |
| 06/08/2000 | WO1999058095A3 Pharmaceutical and/or cosmetic compositions containing sea water |
| 06/08/2000 | WO1999024076A9 Salicylate derivatized therapeutic and diagnostic agents |
| 06/08/2000 | DE19855890A1 Poröse Kompositmatrix, deren Herstellung und Verwendung Porous composite matrix, their preparation and use |
| 06/08/2000 | DE19855881A1 Verfahren zur Aktivierung von Wasser und Verwendung derartig aktivierten Wassers Process for the activation of water and use of such activated water |
| 06/08/2000 | CA2354187A1 Calcitonin for the modulation of sperm function |
| 06/08/2000 | CA2353590A1 Isolated material having an anti-organotrophic effect |
| 06/08/2000 | CA2353521A1 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof |
| 06/08/2000 | CA2353499A1 Method for activating water and use of activated water of this type |
| 06/08/2000 | CA2352810A1 Spray delivery of cells |
| 06/08/2000 | CA2352785A1 Submucosa modulation of mammalian immune response |
| 06/08/2000 | CA2352749A1 Anti-dandruff composition comprising an antifungal polypeptide |
| 06/08/2000 | CA2351671A1 Transgenic circulating endothelial cells |
| 06/08/2000 | CA2347677A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2000 | EP1006182A2 Polypeptide fragments of factor VIIIC, corresponding probes and DNA sequences and DNA constructs |
| 06/07/2000 | EP1006124A1 Immunomodulatory and antimicrobial materials, their preparation and use |
| 06/07/2000 | EP1005871A2 Trapped cells and use thereof as a drug |
| 06/07/2000 | EP1005867A2 Botulinum toxins for modulating cholinergic controlled secretions |
| 06/07/2000 | EP1005866A2 Allogeneic and xenogeneic transplantation |
| 06/07/2000 | EP1005789A2 Quiescent cell populations for nuclear transfer |
| 06/07/2000 | EP1005538A1 Gene therapy for alleviating erectile dysfunction |
| 06/07/2000 | EP1005531A2 Method of treating leukocytes, leukocyte compositions and methods of use thereof |
| 06/07/2000 | EP1005371A2 Method and food product for increasing muscle protein and reducing fat in animals |
| 06/07/2000 | EP1005360A1 Antioxidant protein 2, gene and methods of use therefor |
| 06/07/2000 | EP1005353A1 Pharmaceutical preparation comprising lactobacillus casei rhamnosus |
| 06/07/2000 | EP1005331A1 Transplants coated with autologous endothelial cells |
| 06/07/2000 | EP1005273A1 CONTROL OF ENTEROHEMORRHAGIC $i(E. COLI) O157:H7 IN CATTLE BY PROBIOTIC BACTERIA |
| 06/07/2000 | EP0775010A4 Blood collection system deriving instantaneous component yield |
| 06/07/2000 | CN2381141Y Deodorizer for hydrolytic liquid of sheep placenta |
| 06/07/2000 | CN1255374A Medicine for curing diseases in nerve system and its preparing process |
| 06/07/2000 | CN1255368A Chinese medicine for lowering blood pressure |
| 06/07/2000 | CN1255351A Decrustation ointment for burn and its preparing process |
| 06/07/2000 | CN1255349A Compound Chinese medicine for treating diabetes |
| 06/07/2000 | CN1255348A Medicine for treating gynopathy |
| 06/07/2000 | CN1255344A Typhlosis-resistant liquid for ophthalmopathy as complication of diabetes |
| 06/07/2000 | CN1255340A Chinese medicine for treating rheumatoid arthritis |
| 06/07/2000 | CN1255339A Chinese-medicinal instant particles for promoting milk secretion and recovery of puerperant |
| 06/07/2000 | CN1255338A Medicine for treating anorexia |
| 06/07/2000 | CN1255337A Medicine for treating hydrocephalus |
| 06/07/2000 | CN1255335A Cathartic |
| 06/07/2000 | CN1053114C Medicine for curing bilestone and biliary calculus |
| 06/07/2000 | CN1053110C Prescription of Chinese medicine for treating cholecystitis, cholelithiasis, hepatitis and cholehepatocirrhosis |
| 06/07/2000 | CN1053108C Chinese medicine for treating primary liver cancer |
| 06/07/2000 | CN1053105C Plaster for activating collaterals to relieve pain |
| 06/07/2000 | CA2267673A1 Improvements in and relating to the manufacture of dried products |
| 06/06/2000 | US6072029 Derivatives of human α1 -antitrypsin and process for their preparation |
| 06/06/2000 | US6071963 Water dispersible compositions |
| 06/06/2000 | US6071889 In vivo genetic modification of growth factor-responsive neural precursor cells |
| 06/06/2000 | US6071747 Human preadipocytes for developing antiobesity and antidiabetic agents; cells include immortalizing fragment of viral oncogene, promoter from viral oncogene or human vimentin gene, and express certain proteins |
| 06/06/2000 | US6071731 Enzymatic polypeptide for the attachment of histidine to transfer ribonucleic acid molecule; bactericides; wound healing agents |
| 06/06/2000 | US6071517 Induction of effector-cell-mediated cytolysis; antitumor agents |
| 06/06/2000 | US6071512 Administering replication defective recombinant retrovirion with gene operable linked to control sequence |
| 06/06/2000 | US6071509 Enhanced activation of natural killer cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor |
| 06/06/2000 | CA2179881C Skin substitute using marine organisms |
| 06/04/2000 | CA2291356A1 Recombinant, adenoviral vector having limited autoreplication capability in vivo |
| 06/02/2000 | WO2000031285A1 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells |
| 06/02/2000 | WO2000031280A2 Use of plus-strand synthesis elements in retroviral vectors |
| 06/02/2000 | WO2000031238A2 Methods and reagents for increasing proliferative capacity and preventing replicative senescence |
| 06/02/2000 | WO2000031126A2 Suppression of xenotransplant rejection |
| 06/02/2000 | WO2000031115A1 Methods of identifying antigen gene sequences |
| 06/02/2000 | WO2000030695A1 Mucosal epithelial cell sheet and method for producing the same |
| 06/02/2000 | WO2000030675A2 Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
| 06/02/2000 | WO2000030668A2 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 06/02/2000 | WO2000030665A1 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases |
| 06/02/2000 | WO2000030661A1 Bacteriostatic compositions for salmonellae |
| 06/02/2000 | WO2000030425A2 Method of using pon-1 to decrease atheroma formation |
| 06/02/2000 | WO2000014244A3 Treatment of cervical cancer |
| 06/02/2000 | WO2000011139A9 Cell population containing non-fetal hemangioblasts and method for producing same |
| 06/02/2000 | WO2000009179A3 Methods, instruments and materials for chondrocyte cell transplantation |
| 06/02/2000 | CA2352585A1 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases |
| 06/02/2000 | CA2352486A1 Methods and reagents for increasing proliferative capacity and preventing replicative senescence |
| 06/02/2000 | CA2352043A1 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 06/02/2000 | CA2351736A1 Methods of identifying antigen gene sequences |
| 06/02/2000 | CA2351630A1 Vector |
| 06/02/2000 | CA2350405A1 Method of using pon-1 to decrease atheroma formation |